Woodstock Corp Has $2.84 Million Position in Thermo Fisher Scientific Inc (NYSE:TMO)

Woodstock Corp cut its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,270 shares of the medical research company’s stock after selling 125 shares during the quarter. Woodstock Corp’s holdings in Thermo Fisher Scientific were worth $2,839,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Proficio Capital Partners LLC increased its position in Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares during the period. Sharkey Howes & Javer increased its position in Thermo Fisher Scientific by 1.0% in the 1st quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares during the period. FNY Managed Accounts LLC bought a new position in Thermo Fisher Scientific in the 1st quarter worth approximately $153,000. Penserra Capital Management LLC increased its position in Thermo Fisher Scientific by 9.5% in the 1st quarter. Penserra Capital Management LLC now owns 1,150 shares of the medical research company’s stock worth $176,000 after buying an additional 100 shares during the period. Finally, Independent Portfolio Consultants Inc. increased its position in Thermo Fisher Scientific by 67.5% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,223 shares of the medical research company’s stock worth $213,000 after buying an additional 493 shares during the period. Institutional investors and hedge funds own 83.52% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was first posted by BBNS and is the sole property of of BBNS. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://baseballnewssource.com/markets/woodstock-corp-sells-125-shares-of-thermo-fisher-scientific-inc-tmo/1604862.html.

In other news, VP Peter E. Hornstra sold 3,894 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares in the company, valued at $3,657,490.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the transaction, the director now owns 5,312 shares of the company’s stock, valued at $961,312.64. The disclosure for this sale can be found here. Insiders have sold 22,738 shares of company stock valued at $4,021,512 over the last quarter. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc (NYSE TMO) traded down 0.34% during trading on Friday, reaching $191.04. The company’s stock had a trading volume of 895,029 shares. The stock has a market cap of $74.53 billion, a P/E ratio of 33.28 and a beta of 1.05. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30. The company’s 50 day moving average price is $179.77 and its 200-day moving average price is $170.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. During the same period last year, the business posted $2.03 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 10.2% compared to the same quarter last year. Equities analysts forecast that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. Thermo Fisher Scientific’s payout ratio is 10.45%.

TMO has been the topic of a number of research reports. Bank of America Corporation restated a “buy” rating and set a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Cowen and Company restated an “outperform” rating and set a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Cantor Fitzgerald initiated coverage on Thermo Fisher Scientific in a research report on Thursday, May 18th. They set an “overweight” rating and a $194.00 price objective on the stock. Finally, BidaskClub cut Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. One research analyst has rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $193.56.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with our FREE daily email newsletter.

 


Latest News

Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game


Leave a Reply

 
© 2006-2017 BBNS.